In addition to mRNA upregulation, we searched for other molecular alterations of PDL1 in breast cancer and showed for the first time that copy number alterations are rare (<5%), even if this rate was higher in basal tumors and correlated with a higher rate of mRNA overexpression. The gene discussed is CD274; the disease is breast carcinoma.